Quant Large & Mid Cap Fund - Growth - Regular Plan

Other Plans and Options
  • (-1.67%)Nav, as on 18-01-2021

  • Previous Nav

  • Net Change on 18-01-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate capital appreciation & provide long term growth opportunities by investing in a portfolio of Large Cap and Mid Cap companies. There is no assurance that the investment objective of the Scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Quant Large & Mid Cap Fund - Growth Option 7.65 29.83 32.54 7.90 15.97 12.19
Nifty LargeMidcap 250 Index 6.20 26.99 21.24 6.33 N/A 9.03

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Quant Large & Mid Cap Fund - Growth Option Dec 11, 2006 32.54 7.90 15.97 2.48 7.40
Mirae Asset Emerging Bluechip Fund - Regular Plan - Growth Option Jul 09, 2010 24.94 10.91 20.04 1.70 14,302.17
Canara Robeco Emerging Equities - Regular Plan - GROWTH Mar 11, 2005 24.54 7.74 16.69 1.90 7,312.85
DSP Equity Opportunities Fund-Regular Plan - Growth May 16, 2000 17.62 6.42 14.96 1.90 5,535.37
Aditya Birla Sun Life Equity Advantage Fund - Regular Growth Feb 24, 1995 18.58 4.76 13.39 1.98 4,900.86
Kotak Equity Opportunities Fund - Growth Sep 09, 2004 17.36 8.62 15.44 1.96 4,632.66

Fund Holdings as on 31-December-2020

  • Sun Pharmaceuticals Industries Ltd

  • Fortis Healthcare Ltd

  • Adani Ports & Special Economic Zone Ltd

  • Bharti Airtel Limited

  • HCL Technologies Ltd.

  • Infosys Ltd.

  • Alembic Pharmaceuticals Limited

  • Adani Enterprises Ltd

  • Hindustan Unilever Ltd.

  • Divis Laboratories Ltd.

  • Aarti Industries Ltd

  • PI Industries Ltd

  • Zydus Wellness Ltd

  • Nestle India Ltd.

  • Mphasis Ltd

  • Dabur India Ltd

  • Godrej Agrovet Limited

  • Cadila Healthcare Ltd

  • ICICI Lombard General Insurance Company Ltd.

  • TREPS

  • ICICI Prudential Life Insurance Co Ltd

  • Torrent Pharmaceuticals Ltd

  • Mind Tree Ltd.

  • Oracle Financial Services Software Ltd

  • Jubilant Life Sciences Ltd

  • NCA-NET CURRENT ASSETS

View More

  • Pharmaceuticals & Drugs

  • IT - Software

  • Consumer Food

  • Hospital & Healthcare Services

  • Port

  • Telecommunication - Service Provider

  • Household & Personal Products

  • Trading

  • Chemicals

  • Pesticides & Agrochemicals

  • Insurance

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About Quant Large & Mid Cap Fund

NULL

Scheme Analysis

Quant Large & Mid Cap Fund is a Equity - Large & Mid Cap Fund fund and belongs to Quant Mutual Fund. It was launched on 11-Dec-2006 and currently has an AUM of ₹7.40 crore. Quant Large & Mid Cap Fund is benchmarked against Nifty LargeMidcap 250 Index as primary index.

The NAV of Quant Large & Mid Cap Fund ended down ₹-0.85(-1.67%)yesterday to ₹49.8413.

Among its top 3 holdings the fund has exposure to Sun Pharmaceuticals Industries Ltd, and

The Quant Large & Mid Cap Fund is managed by Sanjeev Sharma and Vasav Sahgal.

Fund House Contact

11, Scindia House, Connaught Circus, New Delhi - 110 001

011-43587415, 43587420
help@quant.in
011-43587432